Summary

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 continues nearly 18 months later to present significant challenges to health systems and public health in both hemispheres, as well as the economies of every country. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed many hospitals and clinics and continue to do so in many countries. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health. This entry collection aims to gather diverse fields about COVID-19, including in epidemiology, public health, medicine, genetics, systems biology, informatics, data science, engineering, sociology, anthropology, nursing, environmental studies, statistics, and psychology.

Expand All
Entries
Topic Review
Magnesium and COVID-19
Magnesium is the fourth most common mineral in the human body and the second richest intracellular cation. This element is necessary for many physiological reactions, especially in the cardiovascular and respiratory systems. COVID-19 is an infectious disease caused by SARS-CoV-2. The majority of people who become ill as a result of COVID-19 have mild-to-moderate symptoms and recover without specific treatment. Moreover, there are people who develop severe forms of COVID-19, which require highly specialized medical assistance. Magnesium deficiency may play a role in the pathophysiology of infection with SARS-CoV-2. The primary manifestation of COVID-19 remains respiratory, but the virus can spread to other organs and tissues, complicating the clinical picture and culminating in multiorgan failure. The key mechanisms involved in the disease include direct viral cytotoxicity, endothelial dysfunction, and exaggerated release of inflammatory cytokines. 
  • 1.2K
  • 24 Feb 2023
Topic Review
Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis
Liver cirrhosis is followed by a profound immune dysfunction characterized by alterations in innate (decreased complement activity, reduced chemotaxis, and phagocytosis) and adaptive immunity (decreased memory cells, CD4 helper cells, T cell exhaustion) which leads to an inadequate immune response against a wide range of pathogens. The pathogenesis of what is known as ‘cirrhosis-associated immune dysfunction’ resides mainly in impairment of the hepatic reticulo-endothelial system, defective protein production, blood cell dysfunction, and systemic inflammation that is related to hepatocyte destruction.
  • 485
  • 21 Feb 2023
Topic Review
Post-COVID-19 Cardiopulmonary Rehabilitation
Managing cardiopulmonary rehabilitation in patients with COVID-19 remains a global challenge due to the facets of this virus. The technologies used in the rehabilitation of post-COVID-19 patients fail to keep pace with the global epidemiological developments.
  • 599
  • 21 Feb 2023
Topic Review
Carbazoles Treatment for COVID-19 Infection
Several treatment approaches for COVID-19 were employed since the beginning of the pandemic, such as immunomodulatory, antiviral, anti-inflammatory, antimicrobial agents, and again corticosteroids, angiotensin II receptor blockers, and bradykinin B2 receptor antagonists, but many of them were proven ineffective in targeting the virus. So, the identification of drugs to be used effectively for treatment of COVID-19 is strongly needed. Carbazoles represent an interesting class of heterocycles known by their anticancer activity: antibacterial, anti-inflammatory, antifungal, antioxidant, antimicrobial, antiepileptic, antihistamine, antiviral. In addition, numerous carbazole derivatives have also been found to be useful for Alzheimer’s disease. 
  • 800
  • 21 Feb 2023
Topic Review
T Cells and Adaptive Immune System in SARS-CoV-2
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Prior COVID-19 research on immunogens understandably focused on nAb responses, with less interest in overall cellular immunity. Interestingly, there is data accumulating which suggests that T cell responses are an important player in both natural and adaptive immunity as well as vaccine protection against chronic COVID-19 disease.
  • 1.6K
  • 20 Feb 2023
Topic Review
Molecular Simulations of RNA-Dependent RNA Polymerase of SARS-CoV-2
Molecular dynamics (MD) simulations are powerful theoretical methods that can reveal biomolecular properties, such as structure, fluctuations, and ligand binding, at the atomic level. All-atom MD simulations elucidated a difference in the dynamic properties of RNA-dependent RNA polymerases (RdRps) in severe acute respiratory syndrom coronavirus 2 (SARS-CoV-2) and SARS-CoV, which may cause activity differences of these RdRps. RdRp is also a drug target for Coronavirus disease 2019. Nucleotide analogs, such as remdesivir and favipiravir, are considered to be taken up by RdRp and inhibit RNA replication. The recognition mechanism of RdRp for these drug molecules and adenosine triphosphate (ATP) was revealed by MD simulations at the atomic detail. In addition, various simulation studies on the complexes of SARS-CoV-2 RdRp with several nucleotide analogs are also presented.
  • 1.0K
  • 20 Feb 2023
Topic Review
Relationship between Gut Microbiota and SARS-CoV-2 Infection
Gut microbiota is increasingly recognized to play a pivotal role in various human physiological functions and diseases. Amidst the COVID-19 pandemic, research has suggested that dysbiosis of the gut microbiota is also involved in the development and severity of COVID-19 symptoms by regulating SARS-CoV-2 entry and modulating inflammation.
  • 650
  • 17 Feb 2023
Topic Review
Impedimetric Sensing
The COVID-19 pandemic revealed a pressing need for the development of sensitive and low-cost point-of-care sensors for disease diagnosis. The standard of care for COVID-19 is quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). This method is sensitive, but takes time, effort, and requires specialized equipment and reagents to be performed correctly. This make it unsuitable for widespread, rapid testing and causes poor individual and policy decision-making. Rapid antigen tests (RATs) are a widely used alternative that provide results quickly but have low sensitivity and are prone to false negatives, particularly in cases with lower viral burden. Electrochemical sensors have shown much promise in filling this technology gap, and impedance spectroscopy specifically has exciting potential in rapid screening of COVID-19. Due to the data-rich nature of impedance measurements performed at different frequencies, this method lends itself to machine-leaning (ML) algorithms for further data processing.
  • 704
  • 16 Feb 2023
Topic Review
New Discovered Molecules of COVID-19
New molecules/drugs are discovered by humans for the therapeutic management of new diseases or to address existing health challenges. New molecules/drugs require extensive clinical investigations, followed by approval from drug regulatory agencies for marketing.
  • 1.0K
  • 13 Feb 2023
Topic Review
COVID-19 Prevention and Treatment Approaches
COVID-19 is an infectious disease declared as a pandemic on 11 March 2020 by the World Health Organization (WHO). As the pandemic evolved, so did the search for potential prophylactic and therapeutic agents. Several therapies have been developed, including vaccines, antivirals, monoclonal antibodies, and others. 
  • 649
  • 08 Feb 2023
  • Page
  • of
  • 74
>>